---
$id: https://graph.org.ai/products/commodity/51313405
$type: Product
source: UNSPSC
code: "51313405"
title: "Carbinoxamine or rotoxamine"
class: "51313400"
classTitle: "Antihistamine or H1 blocker pyridines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carbinoxamine or rotoxamine

**UNSPSC Code**: 51313405
**Class**: [Antihistamine or H1 blocker pyridines](Antihistamine or H1 blocker pyridines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 982A7M02H5, chemically known as pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)- but generally known as carbinoxamine, which bears US NIH Compound Identifier 2564. Carbinoxamine most often comes in base and maleate forms. European Medicines Agency schedules Carbinoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06128MIG. The term CARBINOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules carbinoxamine in its Anatomical Therapeutic Chemical (ATC) Classification. CARBINOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Carbinoxamine or rotoxamine bears US NLM identifiers UMLS ID C0054672 and NCI Concept Code C65286. SMILES: CLC1CCC(C(OCCN(C)C)C2NCCCC2)CC1.

